J. Kekow

Comparative effectiveness of tumour necrosis factor α inhibitors in combination with either methotrexate or leflunomide

J. Listing, A. Zink, H. Tony, 2009, Annals of the rheumatic diseases.

Evidence of proteolytic activation of transforming growth factor beta in synovial fluid.

J. Kekow, C. Kühne, S. Zieliński, 2000, Advances in experimental medicine and biology.

Transforming growth factor-beta and suppression of humoral immune responses in HIV infection.

J. McCutchan, M. Zachariah, W. Wachsman, 1991, The Journal of clinical investigation.

Patient-reported outcomes improve with etanercept plus methotrexate in active early rheumatoid arthritis and the improvement is strongly associated with remission: the COMET trial

R. Moots, P. Emery, P. Durez, 2009, Annals of the rheumatic diseases.

Treatment continuation in patients receiving biological agents or conventional DMARD therapy

R. Rau, S. Wassenberg, E. Gromnica-ihle, 2005, Annals of the rheumatic diseases.

Interleukin 10 promoter microsatellite polymorphisms are associated with response to long term treatment with etanercept in patients with rheumatoid arthritis

G. Assmann, W. Domschke, M. Gaubitz, 2004, Annals of the rheumatic diseases.